(Q54425194)

29 May 2018

title

Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli. (English)

1 reference

29 May 2018

Mycobacterium tuberculosis

main subject

0 references

1 reference

4

1 reference

29 May 2018

Michela Sali

Michela Sali

6

0 references

Riccardo Manganelli

Riccardo Manganelli

10

0 references

Ignazio Castagliuolo

Ignazio Castagliuolo

3

0 references

Giorgio Palù

9

Giorgio Palù

1 reference

29 May 2018

Paola Brun

1

1 reference

29 May 2018

Antonella Zumbo

2

1 reference

29 May 2018

Filippo Manfrin

5

1 reference

29 May 2018

Giovanni Fadda

7

1 reference

29 May 2018

Catherine Grillot-Courvalin

8

1 reference

29 May 2018

language of work or name

English

0 references

publication date

25 February 2008

1 reference

29 May 2018

published in

Vaccine

1 reference

29 May 2018

volume

26

1 reference

29 May 2018

issue

16

1 reference

29 May 2018

page(s)

1934-1941

1 reference

29 May 2018

Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Bacterial gene therapy strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Engineered E. coli delivers therapeutic genes to the colonic mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Potential therapeutic applications of recombinant, invasive E. coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Recombinant Escherichia coli as a gene delivery vector into airway epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Functional gene transfer from intracellular bacteria to mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

The TB epidemic from 1992 to 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Introduction. Rational vaccine development against tuberculosis: "Those who don't remember the past are condemned to repeat it".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

7 January 2021

Plasmid DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Mycobacterium tuberculosis and the host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Development of new vaccines and diagnostic reagents against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Tuberculosis vaccines - an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

The mouse as a useful model of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

TB vaccine strategies--what is needed to solve a complex problem?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.023

10.1016/J.VACCINE.2008.02.023

7 January 2021

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018